Caissa Capital Management, 10% Owner of Avalo Therapeutics AVTX, has filed 32 purchases and 0 sales on the open market. The latest trade was on 23/06/26.

CM

CM

Caissa Capital Management

10% Owner

Company

Avalo Therapeutics AVTX

First filing

23/04/24

Trades

34 trades

Buys / sales

32 / 0

12-month net buying

No record

Last trade

23/06/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Avalo TherapeuticsAVTX	Open-market buy	23/06/26	23/06/27	1,608,000 sh2 trades	$0.64avg.	$1,025,474	No record
Avalo TherapeuticsAVTX	Open-market buy	23/06/15–23/06/20	23/06/20	8,160 sh3 trades	$3.87avg.	$31,608.8	+0.6%
Avalo TherapeuticsAVTX	Open-market buy	23/06/12–23/06/14	23/06/14	16,899 sh3 trades	$3.77avg.	$63,631.66	+1.2%
Avalo TherapeuticsAVTX	Open-market buy	23/06/07–23/06/09	23/06/09	14,426 sh3 trades	$3.91avg.	$56,440.46	+1.0%
Avalo TherapeuticsAVTX	Open-market buy	23/05/31	23/06/02	844 sh	$2.87	$2,422.28	+0.1%
Avalo TherapeuticsAVTX	Open-market buy	23/05/25–23/05/30	23/05/30	2,671 sh2 trades	$2.80avg.	$7,465.77	+0.2%
Avalo TherapeuticsAVTX	Open-market buy	23/05/24	23/05/24	9,000 sh2 trades	$2.98avg.	$26,814.05	+0.7%
Avalo TherapeuticsAVTX	Open-market buy	23/05/18–23/05/22	23/05/22	26,621 sh3 trades	$3.36avg.	$89,428.09	+2.0%
Avalo TherapeuticsAVTX	Open-market buy	23/05/12–23/05/16	23/05/16	4,379 sh3 trades	$2.52avg.	$11,013.75	+0.3%
Avalo TherapeuticsAVTX	Open-market buy	23/05/04–23/05/08	23/05/08	25,000 sh3 trades	$2.77avg.	$69,350	+1.9%
Avalo TherapeuticsAVTX	Open-market buy	23/04/25–23/04/27	23/04/27	7,500 sh3 trades	$2.99avg.	$22,427.09	+0.6%
Avalo TherapeuticsAVTX	Open-market buy	23/04/20–23/04/24	23/04/24	17,500 sh2 trades	$3.07avg.	$53,650	+1.4%
Avalo TherapeuticsAVTX	Open-market buy	23/04/17–23/04/18	23/04/18	25,000 sh2 trades	$2.95avg.	$73,800	+2.0%
Avalo TherapeuticsAVTX	Open-market buy	23/04/10–23/04/11	23/04/11	56,329 sh2 trades	$2.53avg.	$142,430.12	+4.7%